Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis

Morbidity and mortality associated with COVID-19 has increased exponentially, and patients with cardiovascular (CV) disease are at risk for poor outcomes. Several lines of evidence suggest a potential role for CV therapies in COVID-19 treatment. Characteristics of clinical trials of CV therapies rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Varshney, Anubodh S., Wang, David E., Bhatt, Ankeet S., Blood, Alexander, Sharkawi, Musa A., Siddiqi, Hasan K., Vaduganathan, Muthiah, Monteleone, Peter P., Patel, Manesh R., Jones, W. Schuyler, Lopes, Renato D., Mehra, Mandeep R., Bhatt, Deepak L., Kochar, Ajar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586939/
https://www.ncbi.nlm.nih.gov/pubmed/33121978
http://dx.doi.org/10.1016/j.ahj.2020.10.065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586939/
https://www.ncbi.nlm.nih.gov/pubmed/33121978
http://dx.doi.org/10.1016/j.ahj.2020.10.065

Ejemplares similares